BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32391554)

  • 1. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.
    Yan Z; Bi M; Zhang Q; Song Y; Hong S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32391554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
    Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
    Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression.
    Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J
    Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451
    [No Abstract]   [Full Text] [Related]  

  • 5. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer.
    Jiang Y; Liu G; Ye W; Xie J; Shao C; Wang X; Li X
    Cancer Biother Radiopharm; 2020 Mar; 35(2):153-162. PubMed ID: 31755734
    [No Abstract]   [Full Text] [Related]  

  • 6. Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.
    Liu Q; Zhang W; Luo L; Han K; Liu R; Wei S; Guo X
    Diagn Pathol; 2021 May; 16(1):47. PubMed ID: 34030715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR-126-5p/ZEB2 axis.
    Lv J; Zhu S; Chen H; Xu Y; Su Q; Yu G; Ma W
    Drug Dev Res; 2022 Apr; 83(2):432-446. PubMed ID: 34636432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lnc LINC00461/miR-30a-5p facilitates progression and malignancy in non-small cell lung cancer via regulating ZEB2.
    Li X; Liu J; Liu M; Xia C; Zhao Q
    Cell Cycle; 2020 Apr; 19(7):825-836. PubMed ID: 32106756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
    Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH
    Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
    Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
    Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA TUG1 facilitates proliferation, invasion and stemness of ovarian cancer cell via miR-186-5p/ZEB1 axis.
    Zhan FL; Chen CF; Yao MZ
    Cell Biochem Funct; 2020 Dec; 38(8):1069-1078. PubMed ID: 32390141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1-miR-145-5p-TRPC6 pathway.
    Wang X; Bai X; Yan Z; Guo X; Zhang Y
    Biochem Cell Biol; 2021 Apr; 99(2):249-260. PubMed ID: 32985219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
    Feng S; Liu W; Bai X; Pan W; Jia Z; Zhang S; Zhu Y; Tan W
    Cancer Lett; 2019 Nov; 465():105-117. PubMed ID: 31499118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2.
    Liu A; Liu L; Lu H
    J Cell Physiol; 2019 Aug; 234(8):13747-13761. PubMed ID: 30656681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-coding RNA Zinc Finger Antisense 1 (ZFAS1) Regulates Proliferation, Migration, Invasion, and Apoptosis by Targeting MiR-7-5p in Colorectal Cancer.
    Mo D; Liu W; Li Y; Cui W
    Med Sci Monit; 2019 Jul; 25():5150-5158. PubMed ID: 31295229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA RP11-197K6.1 as ceRNA promotes colorectal cancer progression via miR-135a-5p/DLX5 axis.
    Wang M; Niu X; Wang M; Zheng P; Liu X; Cao Z; Zhang C
    J Transl Med; 2024 May; 22(1):469. PubMed ID: 38760791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.
    Du Y; Liu X; Zhang S; Chen S; Guan X; Li Q; Chen X; Zhao Y
    Reprod Biol Endocrinol; 2021 Nov; 19(1):176. PubMed ID: 34847936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis.
    Dong H; Liu Q; Chen C; Lu T; Xu K
    Immunobiology; 2022 Mar; 227(2):152176. PubMed ID: 35066433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.